Rose Beck

1.1k citations
49 papers · 699 indexed · h-index 14

Rose Beck

45 papers receiving 685 citations

Peers

Rose Beck
Comparison fields: 5 of 78
  • Hematology 172
  • Immunology 266
  • Genetics 122
  • Pathology and Forensic Medicine 188
  • Oncology 262
Replace Alison R. Sehgal with:
Alison R. Sehgal United States
S. Saks United States
Anjum Hassan United States
Evi Regitz Germany
Atsushi� Satake Japan
Andreas K. Klein United States
M. Hirakata Japan
Zhengming Jin China
Naoki Kurita Japan
Luis Fayad United States
Rose Beck relative to Alison R. Sehgal United States Alison R. Sehgal's profile →
Citations per field
00.5×1.5×
Alison R. Sehgal · 1×
Citations per year

Countries citing papers authored by Rose Beck

Since Specialization
Citations

This map shows the geographic impact of Rose Beck's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Rose Beck with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Rose Beck more than expected).

Fields of papers citing papers by Rose Beck

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Rose Beck. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Rose Beck. The network helps show where Rose Beck may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Rose Beck, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Rose Beck Line = papers co-authored together Rose Beck links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown
#Work
1 20254
2 20240
3 20231
4 20213
5 20205
6 20205
7 201910
8 201912
9 201967
10 20186
11 201639
12 201563
13 20112
14 200943
15 20065
16 200521
17 200419
18 200346
19 200325
20 20015

About Rose Beck

Rose Beck is a scholar working on Hematology, Genetics, Pathology and Forensic Medicine, Immunology and Oncology, having authored 49 papers that have together received 699 indexed citations. Recurring topics across this work include Lymphoma Diagnosis and Treatment (11 papers), Chronic Lymphocytic Leukemia Research (8 papers), Acute Myeloid Leukemia Research (8 papers), Multiple Myeloma Research and Treatments (7 papers), Immune Cell Function and Interaction (7 papers), Viral-associated cancers and disorders (6 papers), Monoclonal and Polyclonal Antibodies Research (5 papers) and Acute Lymphoblastic Leukemia research (5 papers). The work is most often cited by research in Hematology (172 citations), Immunology (266 citations), Genetics (122 citations), Pathology and Forensic Medicine (188 citations) and Oncology (262 citations). Rose Beck has collaborated with scholars based in United States, Germany and Switzerland. Frequent co-authors include Eric D. Hsi, Karl S. Theil, Jaroslaw P. Maciejewski, Nikhil H. Ramaiya, Christine L. O’Keefe, Daniel A. Smith, Stephen Moreton, Marcos de Lima, David N. Wald and Sree Harsha Tirumani. Their work appears in journals such as American Journal of Clinical Pathology, Diagnostic Molecular Pathology, Blood, British Journal of Haematology and Journal of Computer Assisted Tomography.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026